Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic Periodontitis

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The present clinical trial was designed to investigate the clinical and microbiological effectiveness of systemic ayurvedic immunomodulator Septilin as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis (CP)

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Government Dental College and Research Institute, Bangalore
• Collaborator: Himalaya Drug Company Ltd. India
• Treatments: Adjuvants, Immunologic; Immunologic Factors

Criteria

Inclusion Criteria:

• age 30 to 50 years

• atleast 12 scorable teeth with a probing depth (PD) ≥ 4 mm not including third molars

• teeth with orthodontic appliances bridges, crowns, or implants

• radiographic evidence of bone loss.

Exclusion Criteria:

• pregnancy or lactation

• smokers

• systemic diseases like diabetes mellitus, immunocompromised patients

• systemic antibiotics taken within the previous 6 months

• use of non-steroidal anti-inflammatory drugs

• sub-gingival SRP or surgical periodontal therapy in the previous year.